Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease
Authors
Reynolds, DM
Hayashi, T
Cai, YQ
Veldhuisen, B
Watnick, TJ
Lens, XM
Mochizuki, T
Qian, F
Maeda, Y
Li, L
Fossdal, R
Coto, E
Wu, GQ
Breuning, MH
Germino, GG
Peters, DJM
Somlo, S
Citation
Dm. Reynolds et al., Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease, J AM S NEPH, 10(11), 1999, pp. 2342-2351
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
SICI code
1046-6673(199911)10:11<2342:ASITPG>2.0.ZU;2-T
Abstract
It is estimated that approximately 15% of families with autosomal dominant
polycystic kidney disease (ADPKD) have mutations in PKD2, Identification of
these mutations is central to identifying functionally important regions o
f gene and to understanding the mechanisms underlying the pathogenesis of t
he disorder. The current study describes mutations in six type 2 ADPKD fami
lies. Two single base substitution mutations discovered in the ORF in exon
14 constitute the most COOH-terminal pathogenic variants described to date.
One of these mutations is a nonsense change and the other encodes an appar
ent missense variant. Reverse transcription-PCR from patient. lymphoblast R
NA showed that, in addition, both mutations resulted in out-of-frame splice
variants by activating cryptic splice sites via different mechanisms. The
apparent missense variant produced such a strong splicing signal that the p
rocessed transcript from the mutant chromosome did not contain any of the n
ormally spliced, missense product. A third mutation, a nonconservative miss
ense change effecting a negatively charged residue in the third transmembra
ne span, is likely pathogenic and defines a highly conserved residue consis
tent with a potential channel subunit function for polycystin-2. The remain
ing three mutations included two frame shifts resulting from deletion of on
e or two bases in exons 6 and 10, respectively, and a nonsense mutation due
to a single base substitution in exon 4. The study also defined a novel-in
tragenic polymorphism in exon 1 that will be useful in analyzing "second hi
ts" in PKD2. Finally, the study demonstrates that there are reduced levels
of normal polycystin-2 protein in lymphoblast lines from PKD2-affected indi
viduals and that truncated mutant polycystin-2, cannot be detected in patie
nt lymphoblasts, suggesting that the latter may be unstable in at least som
e tissues. The mutations described will serve as critical reagents for futu
re functional studies in PKD2.